AARD
Aardvark Therapeutics, Inc. Common Stock
NASDAQ: AARD · HEALTHCARE · BIOTECHNOLOGY
$5.21
-6.80% today
Updated 2026-04-29
Market cap
$113.66M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.93
Dividend yield
—
52W range
$3 – $18
Volume
0.3M
Aardvark Therapeutics, Inc. Common Stock (AARD) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | $16.76M | $10.54M | $77.51M |
| Cash & equivalents | $15.56M | $9.73M | $61.64M |
| Current assets | $16.49M | $10.37M | $74.14M |
| Total liabilities | $44.68M | $45.34M | $132.15M |
| Current liabilities | $595000.00 | $1.38M | $4.93M |
| Long-term debt | — | — | — |
| Shareholder equity | $-27.92M | $-34.80M | $-54.64M |
| Retained earnings | $-30.53M | $-37.74M | $-58.33M |
| Accounts receivable | — | — | — |
| Inventory | — | — | — |
| Goodwill | — | — | — |